Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
I
Imexpharm Corp
VN:IMP
Imexpharm Corp
VN:IMP
Price:
35 100
VND
-0.28%
Market Cap:
₫5.4T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
IMP Price Forecast
Based on 4 analysts
Based on 4 analysts
+63% Upside
from
₫35 100
today
Imexpharm Corp (IMP)’s 12-month stock price forecast through November 2027 has a consensus target of ₫57 120, implying 63% upside. The forecast is based on price targets from 4 Wall Street analysts.
Imexpharm Corp Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMP's stock price target?
Price Target
57 120
VND
57 120
VND
According to Wall Street analysts, the average 1-year price target for IMP is 57 120 VND with a low forecast of 47 571 VND and a high forecast of 59 325 VND.
What is the Revenue forecast for Imexpharm Corp?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 18%.
What is the Gross Profit forecast for Imexpharm Corp?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Imexpharm Corp?
Projected CAGR
23%
23%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 23%.
What is the Pre-Tax Income forecast for Imexpharm Corp?
Projected CAGR
21%
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Imexpharm Corp?
Projected CAGR
28%
28%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 28%.